AIG
VBIV

American International Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

American International Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,102
Closed -$28.2K – 3197
2023
Q1 		$28.2K Buy
3,102
+62
+2% +$878 ﹤0.01% 2848
2022
Q4 		$35.7K Sell
3,040
-11
-0.4% -$194 ﹤0.01% 2840
2022
Q3 		$65K Buy
3,051
+43
+1% +$1.16K ﹤0.01% 2741
2022
Q2 		$73K Sell
3,008
-111
-4% -$3.78K ﹤0.01% 2743
2022
Q1 		$155K Sell
3,119
-220
-7% -$10.9K ﹤0.01% 2397
2021
Q4 		$234K Sell
3,339
-58
-2% -$4.89K ﹤0.01% 2275
2021
Q3 		$317K Sell
3,397
-81
-2% -$7.7K ﹤0.01% 2141
2021
Q2 		$350K Sell
3,478
-23
-0.7% -$2.24K ﹤0.01% 2156
2021
Q1 		$327K Buy
3,501
+9
+0.3% +$913 ﹤0.01% 2084
2020
Q4 		$288K Buy
3,492
+69
+2% +$5.88K ﹤0.01% 2078
2020
Q3 		$294K Sell
3,423
-78
-2% -$9.09K ﹤0.01% 1899
2020
Q2 		$326K Buy
3,501
+479
+16% +$26.4K ﹤0.01% 1830
2020
Q1 		$86K Sell
3,022
-175
-5% -$6.8K ﹤0.01% 2400
2019
Q4 		$132K Buy
3,197
+1,431
+81% +$31.3K ﹤0.01% 2465
2019
Q3 		$25K Sell
1,766
-12
-0.7% -$251 ﹤0.01% 3001
2019
Q2 		$63K Buy
+1,778
New +$96.4K ﹤0.01% 2886
2018
Q2 		– Sell
-736
Closed -$77K – 3127
2018
Q1 		$77K Sell
736
-40
-5% -$4.77K ﹤0.01% 2778
2017
Q4 		$99K Buy
776
+291
+60% +$35.8K ﹤0.01% 2739
2017
Q3 		$56K Buy
485
+36
+8% +$4.32K ﹤0.01% 2790
2017
Q2 		$59K Buy
+449
New +$60.6K ﹤0.01% 2960

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American International Group's VBIV Position: Q2 2023 in Review

American International Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 3,102 shares — an estimated $28.2K sold.

American International Group first reported a position in VBIV in Q2 2017 and held it in 20 quarters. The position peaked at $350K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • American International Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 3,102 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $28.2K.
  • American International Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 20 quarters.
  • American International Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $350K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.